If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback